Managing Editor, Europe
Latest From Tom Gallen
Algae With Claimed Immunity Benefits Gets EU Nod For Supplement Use
An algae extract that is claimed to support the immune system while helping to protect against oxidative stress has obtained a positive opinion as a novel food in the European Union.
People On The Move: Appointments At AESGP, Alliance Pharma, FSE, Venture Life
A round-up of the latest appointments in Europe's consumer health industry: AESGP names Haleon's Workman as president; Alliance Pharma shareholders re-elect board; Food Supplements Europe re-elects Stada's Šímová as chair; and Venture Life announces departure of co-Founder and CCO Daly.
Sweden Drops Plans For Max Levels In Supplements After Commission Consultation
Sweden will not introduce proposed limits for vitamin D and iodine in dietary supplements after the European Commission warned it would create a disproportionate barrier to trade with other EU member states.
Nestlé's Iron Deficiency Supplement Among Latest EU Novel Food Authorizations
A new source of iron manufactured by Nestlé is one of four novel foods to receive authorization by the European Commission for use in dietary supplements.
People On The Move: Appointments At ANEFP, CHPA, Norgine, InfectoPharm, DSM
A round-up of the latest appointments in Europe's and the US health and wellness industries: Spain's ANEFP elects Martín as president; US CHPA appoints Parks as senior VP of regulatory and scientific affairs, Norgine hires HRA's Hilton to lead its consumer business; Infectopharm names Weleda's Ammendola as R&D head; and DSM-Firmenich makes management changes.
UK Rejects Rx-To-OTC Switch Of Overactive Bladder Treatment
Maxwellia’s application to switch to non-prescription status in the UK Aquiette (oxybutynin hydrochloride) for the treatment of overactive bladder has been rejected by MHRA following a public consultation.